ReachMD

Episodes 1-15 of 47

• • 

    

    John J. Russell, MD

    Peer

  • 

    

    Steven W. Pipe, MD

    Peer

  4

  

  RestartResume

  Personalizing Prophylaxis for Hemophilia A and B:
  A New Era in Treatment and Management

  Personalizing Prophylaxis for Hemophilia A and B:
  A New Era in Treatment and Management

  0.50 credits

• • 

    

    Joseph Mikhael, MD, MEd, FRCPC, FACP

    Peer

  3

  

  RestartResume

  Multiple Myeloma Newsflash: Emerging Data From the 2020 ASH Annual Meeting

  Multiple Myeloma Newsflash: Emerging Data From the 2020 ASH Annual Meeting

  0.25 credits

• • 

    

    Jennifer W. Carlisle, MD

    Peer

  • 

    

    Suresh S. Ramalingam, MD

    Peer

  4

  

  RestartResume

  An Evolving Clinical Landscape in HER2+ and HER2-Mutant Metastatic NSCLC: Critical Updates for Your Practice

  An Evolving Clinical Landscape in HER2+ and HER2-Mutant Metastatic NSCLC: Critical Updates for Your Practice

  0.50 credits

• • 

    

    Yohann Loriot, MD, PhD

    Peer

  • 

    

    Robert J. Motzer, MD

    Peer

  6

  

  RestartResume

  Principles and Practice Strategies for Immunotherapy in Genitourinary Malignancies

  Principles and Practice Strategies for Immunotherapy in Genitourinary Malignancies

  1.00 credits

• • 

    

    Richard S. Finn, MD

    Peer

  • 

    

    Amit Singal, MD, MS

    Peer

  • 

    

    Mark Yarchoan, MD

    Peer

  6

  

  RestartResume

  Unresectable HCC: An Emerging Era of Combination Therapy – A Clinical Convergence^®

  Unresectable HCC: An Emerging Era of Combination Therapy – A Clinical Convergence^®

  0.75 credits

• • 

    

    Edward Chu, MD

    Peer

  • 

    

    Michael J. Overman, MD

    Peer

  6

  

  RestartResume

  Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer

  Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer

  0.25 credits

• • 

    

    Jeffrey S. Weber, MD, PhD

    Peer

  3

  

  RestartResume

  Kimberly’s Concerning Mole: Exploring First-Line Treatment Strategies for Patients with Advanced Metastatic Melanoma

  Kimberly’s Concerning Mole: Exploring First-Line Treatment Strategies for Patients with Advanced Metastatic Melanoma

  0.25 credits

• • 

    

    Ajay K. Gopal, MD

    Peer

  0

  

  RestartResume

  Expert Answers to Common Questions for Advancing the Standard of Care for Relapsed/Refractory Follicular Lymphoma

  Expert Answers to Common Questions for Advancing the Standard of Care for Relapsed/Refractory Follicular Lymphoma

  0.25 credits

• • 

    

    Robert Mocharnuk, MD

    Peer

  • 

    

    Pelin Cinar, MD, MS

    Peer

  • 

    

    Malika Fair, MD, MPH, FACEP

    Peer

  6

  

  RestartResume

  The COVID-19 Chronicles: Real-World Perspectives on Cancer Care, Emergency Medicine and Healthcare Disparities

  The COVID-19 Chronicles: Real-World Perspectives on Cancer Care, Emergency Medicine and Healthcare Disparities

  1.00 credits

• • 

    

    Paul P. Doghramji, MD, FAAFP

    Peer

  • 

    

    Corey S. Cutler, MD, MPH, FRCPC

    Peer

  • 

    

    Doris M. Ponce, MD

    Peer

  6

  

  RestartResume

  Breakthroughs and Innovations: Managing Complex Cases in Graft-versus-Host Disease

  Breakthroughs and Innovations: Managing Complex Cases in Graft-versus-Host Disease

  0.50 credits

• • 

    

    Marianne J. Davies, DNP, ACNP, AOCNP

    Peer

  • 

    

    Julie R. Brahmer, MD, MSc

    Peer

  4

  

  RestartResume

  Addressing Barriers in Managing IRAEs Associated with Immune Checkpoint Inhibitor Therapy

  Addressing Barriers in Managing IRAEs Associated with Immune Checkpoint Inhibitor Therapy

  0.25 credits

• • 

    

    Timothy Fenske, MD, MS

    Peer

  0

  

  RestartResume

  Part 1: Improving Risk-based Management Decisions in Follicular Lymphoma

  Part 1: Improving Risk-based Management Decisions in Follicular Lymphoma

  0.50 credits

• • 

    

    Timothy Fenske, MD, MS

    Peer

  5

  

  RestartResume

  Part 2: Improving Risk-based Management Decisions in Follicular Lymphoma

  Part 2: Improving Risk-based Management Decisions in Follicular Lymphoma

  0.50 credits

• • 

    

    Ruben A. Mesa, MD, FACP

    Peer

  4

  

  RestartResume

  Part 2: Improving Quality of Care and Shared Decision-Making in Myelofibrosis

  Part 2: Improving Quality of Care and Shared Decision-Making in Myelofibrosis

  0.50 credits

• • 

    

    Ruben A. Mesa, MD, FACP

    Peer

  5

  

  RestartResume

  Part 1: Improving Quality of Care and Shared Decision-Making in Myelofibrosis

  Part 1: Improving Quality of Care and Shared Decision-Making in Myelofibrosis

  0.50 credits

• 1
• 2
• 3
• 4
• Next